FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics. There are yeast cells walls used in preparing a pharmaceutical composition for treating and/or preventing hyperinsulinemia in a non-diabetic patient. The yeast cell walls have total content of glucans and mannans min. 34.0 wt % of total solids and content of glycogen min. 10.0 wt % of total solids.
EFFECT: use of the declared invention enables higher effectiveness of using the yeast cell walls, as well as effectiveness in preventing and treating hyperinsulinemia caused by insulin resistance, overweight, obesity or metabolic syndrome.
2 ex, 3 tbl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| SEMI-LIQUID FOOD PRODUCT CONTAINING BETA-GLUCAN FIBRES AND GUAR GUM AND SUCH PRODUCT APPLICATION AS A FUNCTIONAL FOOD PRODUCT | 2008 |
|
RU2490919C2 |
| METHOD TO ACTIVATE YEAST GUMS | 2011 |
|
RU2487941C2 |
| METHOD OF PRODUCING BIOLOGICALLY ACTIVE ADDITIVE | 2015 |
|
RU2580050C1 |
| METHOD FOR BIOLOGICAL ACTIVE ADDITIVE PRODUCTION | 2016 |
|
RU2615568C1 |
| METHOD FOR PREPARING WATER-SOLUBLE FRACTIONS OF MANNOPROTEINS AND β-GLUCAN | 2011 |
|
RU2504384C2 |
| GLUCAN COMPOSITIONS | 2007 |
|
RU2490279C2 |
| PHARMACEUTICAL ANTIDIABETIC COMPOSITION BASED ON (+)-CIS-3-(1H-BENZIMIDAZOL-2-YL)-1,2,2-TRIMETHYLCYCLOPENTANE CARBOXYLIC ACID | 2016 |
|
RU2624872C1 |
| METHOD FOR OBTAINING FROM YEAST CELLS OF AT LEAST ONE OR MORE BETA-GLUCAN COMPOUNDS OR SUSPENSION OF SOLID SUBSTANCES CONTAINING BETA-GLUCAN | 2017 |
|
RU2731726C2 |
| NATURAL BIOCOMPOSITE POWDER OBTAINED FROM PICHIA PASTORIS BIOMASS, METHOD FOR ITS PRODUCTION AND APPLICATION AS EXCIPENT | 2013 |
|
RU2631609C2 |
| MEDICATION FOR PREVENTION OF GASTROINTESTINAL TRACT INFECTIONS IN AGRICULTURAL ANIMALS AND POULTRY AND METHOD OF ITS OBTAINING | 2009 |
|
RU2406516C1 |
